
<!DOCTYPE html>
<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Management of HIV and AIDS - HIV/AIDS and STIs Module</title>

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <!-- KaTeX for Math -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <link rel="stylesheet" href="../styles/main.css">
</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Quiz Button -->
    <a href="#topic-quiz" class="floating-quiz-btn" aria-label="Jump to quiz">
        <span class="quiz-btn-icon">üìù</span>
        <span class="quiz-btn-text">Take Quiz</span>
    </a>

    <!-- Reading Progress -->
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">

                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-02-prevention.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Prev: Unit 2</span>
                        </a>

                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>

                        <a href="../quiz-hub.html" class="nav-button nav-button--quiz">
                            <span class="nav-icon">üìù</span>
                            <span class="nav-text">All Quizzes</span>
                        </a>

                        <a href="topic-04-sbcc.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next: SBCC</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                        <span class="progress-text">Unit 03 of 06</span>
                    </div>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span>‚öïÔ∏è</span>
                        <span>Unit 3</span>
                    </div>
                    <h1 class="document-title">Management of HIV and AIDS</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>ART, Nutrition, Counseling, and Care Systems</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>25 min read</span>
                        </div>
                        <div class="meta-item meta-item--quiz">
                            <span>üìù</span>
                            <a href="#topic-quiz">Quiz Available</a>
                        </div>
                    </div>
                </header>

                <!-- Main Content -->
                <main id="main-content" class="content-wrapper">

                    <!-- 3.1 Anti-retroviral therapy (ART) -->
                    <section class="content-section" id="art">
                        <div class="section-header">
                            <div class="section-number">3.1</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Anti-retroviral Therapy (ART)
                            </h2>
                        </div>

                        <div class="content-card content-card--accent">
                            <h3 class="card-title">3.1.1 Goal of ART</h3>
                            <p class="card-intro">The main goal of ART is to suppress viral replication with the aim of reducing the patient‚Äôs VL to undetectable levels. Uninterrupted ART with ongoing strict adherence will help maintain undetectable VL levels thereby; Preventing damage to the body‚Äôs immune system, restoring, maintaining healthy living and educing the risk of sexual and vertical transmission of HIV.</p>
                            
                            <h4 class="mt-4">Other goals of ART therapy:</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">To maintain maximal suppression of the viral load (i.e., fewer than 50 copies per mL).</li>
                                <li class="list-item">Restore or preserve immunity/immunologic function.</li>
                                <li class="list-item">Improve quality of life of PLWHA</li>
                                <li class="list-item">Reduce HIV-related morbidity and mortality.</li>
                                <li class="list-item">Prevent HIV transmission- sexual and vertical transmission of HIV</li>
                            </ul>
                            <div class="callout callout--info">
                                <p>Effective ART consists of a minimum of 3 agents from at least 2 different classes of ARV.</p>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.1.2 Eligibility Criteria</h3>
                            <p>All individuals with confirmed HIV infection are eligible for ART, irrespective of CD4 cell levels, WHO clinical stage, age, pregnancy or breastfeeding status, co-infection status, risk group, or any other criteria.</p>

                            <h3 class="card-title mt-6">3.1.3 Timing of ART Initiation</h3>
                            <p>ART should be started in all patients as soon as possible (preferably within 2 weeks of confirmation of HIV status). ART can be initiated as soon as patients meet the ART Readiness Criteria. Even if it is the same day as enrolment into care. ART initiation on the same day as enrolment into care has additional benefits for HIV prevention (e.g. for pregnant and breastfeeding women, and the HIV positive partner in a discordant relationship), and may have additional mortality benefits for infants less than 12 months of age.</p>

                            <h4 class="mt-4">Special Considerations for Timing of ART Initiation</h4>
                            <div class="process-steps">
                                <div class="process-step">
                                    <div class="step-number">01</div>
                                    <div class="step-content">
                                        <h5 class="step-title">Pregnant, Breastfeeding & Infants < 12 months</h5>
                                        <p class="step-text">Consider ART initiation on the same day as enrolment. Intensive adherence counselling and close follow-up required because of limited time for patient preparation.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">02</div>
                                    <div class="step-content">
                                        <h5 class="step-title">Patients with Strong Motivation</h5>
                                        <p class="step-text">Consider ART initiation as soon as they meet ART Readiness Assessment criteria, even if on the same day as enrolment. Intensive adherence counselling and close follow-up required.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">03</div>
                                    <div class="step-content">
                                        <h5 class="step-title">Patients with newly diagnosed TB</h5>
                                        <p class="step-text">Defer ART until tolerating anti-TB medication; initiate ART within 8 weeks of starting TB treatment (preferably within 2 weeks). Monitor closely for IRIS.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">04</div>
                                    <div class="step-content">
                                        <h5 class="step-title">Patients with Cryptococcal Meningitis (CM)</h5>
                                        <p class="step-text">If treating CM with amphotericin and fluconazole: defer ART until after completing 4 weeks of CM treatment and symptoms have resolved.<br>If treating CM with fluconazole alone: defer ART until after completing 4-6 weeks of CM treatment and symptoms have resolved. Monitor closely for IRIS.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">05</div>
                                    <div class="step-content">
                                        <h5 class="step-title">Adherence Challenges</h5>
                                        <p class="step-text">Start ART as soon as adequate support systems are in place for adherence (e.g. enrolling a PWIDs into a methadone program; psychiatric treatment for a patient with mental illness; caregiver identified for an orphan). A case manager should be assigned to all patients with complex adherence challenges.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">06</div>
                                    <div class="step-content">
                                        <h5 class="step-title">All other patients</h5>
                                        <p class="step-text">Start ART within 2 weeks of HIV diagnosis, once they meet ART Readiness Assessment criteria. Adequate ART preparation, and continued adherence monitoring and support is recommended after ART initiation for all patients.</p>
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="content-card content-card--gradient">
                            <h3 class="card-title">3.1.4 Classes of ARV Drugs</h3>
                            
                            <div class="collapsible-section">
                                <details open>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        1. Nucleoside/nucleotide reverse transcriptase inhibitors (NRTI)
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>They resulting in termination of the growing viral DNA chain. Chain termination can occur during RNA-dependent DNA or DNA-dependent DNA synthesis, inhibiting production of either the (‚àí) or (+) strands of the HIV-1 proviral DNA.</p>
                                        <p><strong>Examples:</strong></p>
                                        <ul class="enhanced-list">
                                            <li>Abacavir (ABC) 300 mg twice daily or 600 mg once daily</li>
                                            <li>Emtricitabine (FTC) 200 mg once daily</li>
                                            <li>Lamivudine (3TC) 150 mg twice daily or 300 mg once daily</li>
                                            <li>Zidovudine (AZT) 300 mg twice daily</li>
                                            <li>Tenofovir disoproxil fumarate (TDF) 300 mg once daily</li>
                                            <li>Tenofovir alfenamide (TAF) 10-25 mg once daily</li>
                                        </ul>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        2. Non-nucleoside reverse transcriptase inhibitors (NNRTI)
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>NNRTIs inhibit HIV-1 RT by binding and inducing the formation of a hydrophobic pocket proximal to, but not overlapping the active site. The binding of NNRTIs changes the spatial conformation of the substrate-binding site and reduces polymerase activity. The resistance generally results from amino acid substitutions such as L100, K101, K103, E138, V179, Y181, and Y188 in the NNRTI-binding pocket of RT.</p>
                                        <p><strong>Examples:</strong></p>
                                        <ul class="enhanced-list">
                                            <li>Efavirenz (EFV) 400‚Äì600 mg once daily</li>
                                            <li>Etravirine (ETV) 200 mg twice daily</li>
                                            <li>Nevirapine (NVP) 200 mg once daily for 14 days followed by 200 mg twice daily</li>
                                        </ul>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        3. Integrase inhibitors
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>All integrase inhibitors in development target the strand transfer reaction and are thus referred to as either INIs or more specifically, integrase strand transfer inhibitors (InSTIs). The selective effect on strand transfer is a result of a now well-defined mechanism of action in which the inhibitor; (1) Binds only to the specific complex between integrase and the viral DNA an (2) Interacts with the two essential magnesium metal ion cofactors in the integrase active site and also the DNA. InSTIs are therefore the only ARV class that interacts with two essential elements of the virus, the integrase enzyme as well as the viral DNA, which is the substrate for integration.</p>
                                        <p><strong>Examples:</strong></p>
                                        <ul class="enhanced-list">
                                            <li>Dolutegravir (DTG) 50 mg once daily</li>
                                            <li>Raltegravir (RAL) 400 mg twice daily</li>
                                        </ul>
                                        <div class="callout callout--warning">
                                            <strong>Considerations for individuals receiving TB therapy:</strong> In the presence of rifampicin, adjusted dose of DTG (50 mg twice daily) and RAL (800 mg twice daily), with close monitoring. In the presence of rifabutin or rifapentine, no dose adjustment is required.
                                        </div>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        4. Protease inhibitors
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>The HIV-1 protease is the enzyme responsible for the cleavage of the viral gag and gag-pol polyprotein precursors during virion maturation.</p>
                                        <p><strong>Examples:</strong></p>
                                        <ul class="enhanced-list">
                                            <li>Atazanavir/ritonavir (ATV/r) 300 mg/100 mg once daily</li>
                                            <li>Darunavir + ritonavir (DRV/r) 800 mg + 100 mg once daily or 600 mg + 100 mg twice daily</li>
                                            <li>Lopinavir/ritonavir (LPV/r) 400 mg/100 mg twice daily</li>
                                        </ul>
                                        <div class="callout callout--warning">
                                            <strong>Considerations for individuals receiving TB therapy:</strong> In the presence of rifampicin, adjusted dose of LPV/r (‚ÄúDouble dose‚Äù LPV 800 mg/ + ritonavir 200 mg twice daily or ‚Äúsuper boosted‚Äù with LPV 400 mg/ + ritonavir 100 mg twice daily plus additional doses of RTV 300 mg twice daily), with close monitoring. In the presence of rifabutin, no dose adjustment required. Rifapentine should not be used.
                                        </div>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        5. Binding inhibitors
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>They target the receptor cells. Target receptors in glycoprotein gp120.</p>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        6. Fusion inhibitors
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>Peptide fusion inhibitors were designed based on the discovery that two homologous domains in the viral gp41 protein must interact with each other to promote fusion, and that mimicry of one of these domains by a heterologous protein can bind and disrupt the intramolecular interactions of the virus protein.</p>
                                    </div>
                                </details>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.1.5 Monitoring and Changing ART</h3>
                            <p>The objectives of clinical and laboratory monitoring during ART are to:</p>
                            <ul>
                                <li>Identify and treat inter-current illnesses</li>
                                <li>Assess for and manage adverse drug reactions</li>
                                <li>Evaluate response to treatment.</li>
                            </ul>

                            <h3 class="card-title mt-6">3.1.6 Indications for changing ART</h3>
                            <ul>
                                <li>Adverse drug reactions (ADRs) or toxicity</li>
                                <li>Drug-drug interactions</li>
                                <li>Co-morbidity</li>
                                <li>Treatment failure</li>
                            </ul>

                            <h3 class="card-title mt-6">3.1.7 Common side effects for ARVs</h3>
                            <div class="columns-2">
                                <ul>
                                    <li>Skins rash-Nevirapine</li>
                                    <li>CNS symptoms (somnolence, insomnia, abnormal dreams, confusion, hallucination, amnesia)- Efavirenz</li>
                                    <li>GI- Nausea, vomiting and diarrhea</li>
                                    <li>Depression</li>
                                    <li>Headache</li>
                                    <li>Liver disease</li>
                                    <li>Spontaneous bleeding</li>
                                    <li>Bone marrow suppression- anaemia</li>
                                    <li>Pancreatitis</li>
                                    <li>Lacto acidosis</li>
                                    <li>Fatigue</li>
                                    <li>Peripheral neuropathy</li>
                                </ul>
                            </div>
                        </div>
                    </section>

                    <!-- 3.2 Nutrition -->
                    <section class="content-section" id="nutrition">
                        <div class="section-header">
                            <div class="section-number">3.2</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü•ó</span>
                                Nutrition in HIV Care
                            </h2>
                        </div>

                        <div class="content-card content-card--accent">
                            <h3 class="card-title">3.2.1 Goal of Nutrition</h3>
                            <p>Good nutrition is a critical component of management of HIV because it contributes to:</p>
                            <div class="feature-grid">
                                <div class="feature-card">
                                    <div class="feature-icon">üõ°Ô∏è</div>
                                    <h4 class="feature-title">Reduce Risk</h4>
                                    <p class="feature-text">Reducing risk and frequency of other infections</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üìâ</div>
                                    <h4 class="feature-title">Delay Progression</h4>
                                    <p class="feature-text">Delaying progression from HIV infection to AIDS</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">‚öñÔ∏è</div>
                                    <h4 class="feature-title">Healthy Weight</h4>
                                    <p class="feature-text">A healthy appearance and weight</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üí™</div>
                                    <h4 class="feature-title">Strength</h4>
                                    <p class="feature-text">Gaining strength, maintaining and building muscle, and having energy to remain active</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üíä</div>
                                    <h4 class="feature-title">Medication Support</h4>
                                    <p class="feature-text">Reducing side effects of ART.</p>
                                </div>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.2.2 Nutritional Assessment, Counselling and Support (NACS)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Anthropometric:</strong> Mid upper arm circumference (MUAC), BMI- Provide interpretation and required actions for anthropometric results for children and adults.</li>
                                <li class="list-item"><strong>Biochemical:</strong> Investigations for baseline and follow-up investigations e.g viral load, CD4 count, pregnancy, urinalysis etc.</li>
                                <li class="list-item"><strong>Clinical:</strong> Physical examination for initial evaluation</li>
                                <li class="list-item"><strong>Dietary:</strong> (24 hour recall for food type/frequency and household food security)</li>
                                <li class="list-item"><strong>Environmental and psychosocial</strong></li>
                                <li class="list-item"><strong>Functional:</strong> (Ability to care for self, bedridden, etc.)</li>
                            </ul>

                            <h3 class="card-title mt-6">3.2.3 Counselling and Education</h3>
                            <ul>
                                <li>Benefits of maintaining good nutritional status for a person living with HIV</li>
                                <li>Mother infant and young child nutrition (MIYCN)</li>
                                <li>Reassuring the client that it is possible to attain/maintain good nutritional status, look well and live a healthy life</li>
                                <li>Identifying locally available foods they can access given their own context, food safety and food preparation</li>
                                <li>Helping the client to plan meals and snacks with a variety of foods in order to meet their energy and nutrient needs and treatment plans</li>
                                <li>Identifying any constraints the client may face and find ways to minimize them</li>
                                <li>Helping the client to understand the potential side effects and food interactions of the medicines they are taking, and help the client identify ways to manage these side effects</li>
                                <li>Exploring with the client the cause(s) of poor appetite and appropriate responses (type of food, disease, pain, depression, anxiety, or side effects of medications)</li>
                                <li>Counselling on high levels of sanitation and food hygiene</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.2.4 Nutritional Support</h3>
                            <ul>
                                <li>Therapeutic and supplementary foods to treat clinical malnutrition (food by prescription, therapeutic feeds, fortified blended four)</li>
                                <li>Complementary foods for children aged 6 - 23 months to prevent malnutrition</li>
                                <li>Micronutrient supplements to prevent vitamin and mineral deficiencies</li>
                                <li>Point-of-use water purification to prevent water-borne disease</li>
                                <li>Food security and linkage to community, such as household food support, home-based care, agricultural extension services, and economic strengthening.</li>
                            </ul>

                            <h3 class="card-title mt-6">3.2.5 Food Security Components of HIV&AIDS</h3>
                            <p>Food security can be attained through linkage to community, such as household food support, home-based care, agricultural extension services, and economic strengthening.</p>

                            <h3 class="card-title mt-6">3.2.6 Relationship between HIV and Nutrition</h3>
                            <p>An HIV-infected person is more at risk for malnutrition for the following reasons:</p>
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>Reduced food intake:</strong> Adults with HIV/AIDS suffer from appetite loss (anorexia) and have difficulty eating.</li>
                                <li class="list-item"><strong>Poor absorption:</strong> HIV/AIDS affects how the body uses the foods that are consumed, resulting in poor absorption of nutrients (protein, carbohydrates, fats, vitamins, minerals and water). Poor absorption of nutrients accompanies diarrhea, which is common with HIV infection.</li>
                                <li class="list-item"><strong>Changes in metabolism:</strong> With poor nutrient absorption, individuals may not be able digest foods efficiently and therefore the body may not be able to use the nutrients properly, particularly fats, carbohydrates and proteins.</li>
                                <li class="list-item"><strong>Chronic infections and illnesses:</strong> Fevers and infections that accompany an HIV infection lead to greater nutrient requirements and poor use of the nutrients by the body.</li>
                            </ol>
                        </div>

                        <div class="content-card content-card--warning">
                            <h3 class="card-title">3.2.7 Illnesses Associated with Nutritional Impacts</h3>
                            <div class="columns-2">
                                <ul>
                                    <li>Anorexia</li>
                                    <li>Diarrhea</li>
                                    <li>Fever</li>
                                    <li>Nausea/frequent vomiting</li>
                                    <li>Thrush</li>
                                    <li>Anaemia</li>
                                </ul>
                            </div>
                            
                            <h4 class="mt-4">Signs of Malnutrition</h4>
                            <div class="columns-2">
                                <ul>
                                    <li>Swollen body and feet</li>
                                    <li>Pale skin, eyes, hair</li>
                                    <li>Lack of blood</li>
                                    <li>Underweight</li>
                                    <li>Thinness</li>
                                    <li>Muscle wasting</li>
                                </ul>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.2.8 Infant and Young Child Feeding in HIV/AIDS</h3>
                            <p>Adequate nutrition is especially important for young children, to ensure they grow properly and have sufficient nutrients to boost their immune systems and fight infection. A malnourished child is more susceptible to various infections, leading to inadequate physical growth, reduced cognitive development and a higher risk of mortality.</p>
                            <p>Because HIV-infected children are at higher risk of malnutrition and growth failure, the following problems should receive special medical attention:</p>
                            <ol>
                                <li>Inadequate food intake resulting from poor appetite, eating very little or high degree of selectivity around food choices.</li>
                                <li>Stomach pain.</li>
                                <li>Feeding difficulties: poor sucking, swallowing or breathing reflex.</li>
                            </ol>

                            <h4 class="mt-4">3.2.8.1 Advantages of Breast Milk/Breast Feeding</h4>
                            <div class="callout callout--success">
                                <ol class="enhanced-list">
                                    <li class="list-item">It is safe, clean, hygienic, cheap and available to infants at correct temperature.</li>
                                    <li class="list-item">It fully meats the nutritional requirements of the infants in the first few months of life.</li>
                                    <li class="list-item">It contains the microbial factors such as macrophages, lymphocytes, secretory, IgA, antistreptococcal which provide protection not only against diarrheal diseases and enterocolitis but also against respiratory tract infections in the first months.</li>
                                    <li class="list-item">It is easily digested and utilized by both the normal and pre term babies.</li>
                                    <li class="list-item">It promotes bonding between the mother and the baby.</li>
                                    <li class="list-item">Sucking is good for the baby- it helps in development of the jaw and teeth.</li>
                                    <li class="list-item">It protects the babies from the tendency to obesity</li>
                                    <li class="list-item">It prevents malnutrition and reduces infant mortality.</li>
                                    <li class="list-item">It provides several bio-chemical advantages such as prevention of neonatal hypocalcaemia and hypo-magnesaemia.</li>
                                    <li class="list-item">It helps parents to space their children by prolonging the period of infertility.</li>
                                </ol>
                            </div>
                        </div>
                    </section>

                    <!-- 3.3 Psychological Counseling -->
                    <section class="content-section" id="psychological">
                        <div class="section-header">
                            <div class="section-number">3.3</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß†</span>
                                Psychological Counseling and Testing
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>People living with HIV are susceptible to psychological disturbances due to HIV itself and perceptions regarding HIV in their environment. Some of the most common psychological disturbances include depression and suicide, anxiety, internalized stigma, post-traumatic stress disorder, cognitive difficulties such as dementia, and perceived lack of social support.</p>

                            <h3 class="card-title mt-4">Depression</h3>
                            <p>People living with HIV (PLHIV) are 3-6 times more likely to suffer from depression than the general population. All PLHIV should receive basic screening for depression before initiating ART and thereafter annually using the following two questions:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">During the past two weeks, have you often been bothered by feeling down, depressed or hopeless?</li>
                                <li class="list-item">During the past two weeks, have you often been bothered by little pleasure in doing things?</li>
                            </ul>

                            <h4 class="mt-4">Supportive Counselling for Depression</h4>
                            <p>Patients with mild depression should receive support counselling, which includes;</p>
                            <ul>
                                <li>Depression is common and can happen to anyone</li>
                                <li>Depressed people often have exaggerated negative opinions about themselves, their life and their future</li>
                                <li>Effective treatment is possible</li>
                                <li><strong>Self-management includes:</strong>
                                    <ul>
                                        <li>Continue ART as prescribed</li>
                                        <li>Continuing activities that they used to find interesting/pleasurable</li>
                                        <li>Maintaining a regular sleep cycle</li>
                                        <li>Keep physically active. Participate in community/social events</li>
                                        <li>Return if any thoughts of self-harm</li>
                                    </ul>
                                </li>
                                <li><strong>Address psychosocial stressors:</strong>
                                    <ul>
                                        <li>Explore potential stressors in the patient‚Äôs life</li>
                                        <li>Assist in problem-solving to reduce stressors</li>
                                        <li>Assess for gender based violence</li>
                                        <li>Referral to social networks e.g support groups</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card content-card--alternate">
                            <h3 class="card-title">3.3.1 Role of CHA in Management of Stigma</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Begin with yourself.</strong> Examine your own attitudes, assumptions, and beliefs about TB/HIV/AIDS and people living with TB, HIV/AIDS.</li>
                                <li class="list-item"><strong>Reach out to your family and community.</strong> Examine the role that you can play to promote dialogue, understanding, and support for people living with TB, HIV, and AIDS in your workplace, family, and community.</li>
                                <li class="list-item"><strong>Learn and grow.</strong> Stigma and discrimination are rooted in ignorance and fear. You can avoid this by following up-to-date information pertaining to TB, HIV/AIDS.</li>
                                <li class="list-item"><strong>Express your knowledge.</strong> Share your knowledge on TB/HIV/AIDS, especially about how TB/HIV is and is not transmitted. Find creative ways and real-life stories to share information with your colleagues, TB patients, family members, and community.</li>
                                <li class="list-item"><strong>Effect change.</strong> As an individual or group, advocate to end TB/HIV/AIDS-related stigma and discrimination in your workplace, family, and the community at large, and promote improved care and support for people living with TB/HIV/AIDS.</li>
                                <li class="list-item"><strong>Think positively.</strong> Speak out and mobilize others to speak out against TB/HIV/AIDS-related stigma and discrimination. Use language that acknowledges and accepts people living with TB/HIV/AIDS as part of your family, workplace, and community. Listen to and honour the courageous voices and experiences of people living with TB, HIV, and AIDS.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- 3.4 & 3.5 ADRs and Defaulter Tracing -->
                    <section class="content-section" id="adr-tracing">
                        <div class="section-header">
                            <div class="section-number">3.4</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìù</span>
                                ADRs and Defaulter Tracing
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.4 Reporting Adverse Drug Reactions (ADRs)</h3>
                            <p>Once patients have been on ART for several months, ADRs are unlikely. ADRs can have a significant impact on patient adherence and must be identified early and managed aggressively. All ADRs should be reported to the Pharmacy and Poisons Board using existing pharmacovigilance tools.</p>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.5 Defaulter Tracing</h3>
                            <p><strong>3.5.1 Definition:</strong> Identifying, Tracing and Supporting Patients who Default from Care. Every service delivery point that is providing ARVs for patients (whether ART, PEP, or PrEP) must have a functional system for identifying patients who miss appointments and for taking action within 24 hours of a missed appointment.</p>

                            <h4 class="mt-4">3.5.2 Steps in identifying, tracing and supporting defaulters</h4>
                            <div class="process-steps">
                                <div class="process-step">
                                    <div class="step-number">i</div>
                                    <div class="step-content">
                                        <p class="step-text">After visit, enter date of next appointment for each patient in the appointment diary.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">ii</div>
                                    <div class="step-content">
                                        <p class="step-text">All patients who had appointment for the day but did not attend should be recorded.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">iii</div>
                                    <div class="step-content">
                                        <p class="step-text">Patients/caregivers should be called within 72 hours of missed appointment. If no response, treatment buddy should be called.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">iv</div>
                                    <div class="step-content">
                                        <p class="step-text">Update patient follow up register with phone call responses.</p>
                                    </div>
                                </div>
                                <div class="process-step">
                                    <div class="step-number">v</div>
                                    <div class="step-content">
                                        <p class="step-text">Can't be reached on phone or unable to return to clinic within 7 days (prioritize home visits). Patient dead or declines further contact- prioritize home visit.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- 3.6 & 3.7 Networking and Referral -->
                    <section class="content-section" id="networking-referral">
                        <div class="section-header">
                            <div class="section-number">3.6</div>
                            <h2 class="section-title">
                                <span class="title-icon">üåê</span>
                                Networking and Referral
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3 class="card-title">3.6 Networking for Access to Care</h3>
                            <p>HIV counselling and testing is just the first step in the continuum of HIV care; a positive HIV diagnosis without linkage to HIV prevention, care and treatment confers limited benefit.</p>
                            
                            <h4 class="mt-4">Reasons for losses include:</h4>
                            <ul>
                                <li><strong>Psychological and social barriers:</strong> Perceived stigma, lack of family support, fear of disclosure.</li>
                                <li><strong>Economic constraints:</strong> Migration for employment, inability to miss work.</li>
                                <li><strong>Health system factors:</strong> Reliance on passive referral, inadequate staffing, long wait times, poor service, poor staff attitudes.</li>
                            </ul>

                            <h4 class="mt-4">3.6.2 Approaches to Improve Linkage to Care and Treatment</h4>
                            <div class="feature-grid">
                                <div class="feature-card">
                                    <div class="feature-icon">‚ÑπÔ∏è</div>
                                    <h4 class="feature-title">Information</h4>
                                    <p class="feature-text">Describe next steps, benefits of immediate assessment, involve patient in decision making.</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üó£Ô∏è</div>
                                    <h4 class="feature-title">Disclosure</h4>
                                    <p class="feature-text">Encourage discussion with trusted friend or relative.</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üöß</div>
                                    <h4 class="feature-title">Barriers</h4>
                                    <p class="feature-text">Identify and address barriers during post-test counselling.</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">ü§ù</div>
                                    <h4 class="feature-title">Facilitation</h4>
                                    <p class="feature-text">Patient escorts, booking appointments, peer/buddy systems, SMS reminders.</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üîÑ</div>
                                    <h4 class="feature-title">Coordination</h4>
                                    <p class="feature-text">Treat mother-baby pairs/partners together. Integrate services (TB, FP, etc.).</p>
                                </div>
                                <div class="feature-card">
                                    <div class="feature-icon">üìã</div>
                                    <h4 class="feature-title">Register</h4>
                                    <p class="feature-text">Maintain linkage register and track progress.</p>
                                </div>
                            </div>
                        </div>

                        <div class="content-card content-card--alternate">
                            <h3 class="card-title">3.7 Criteria for Referral and Referral Procedures</h3>
                            <p><strong>Definition:</strong> Referral is defined as the process through which a client is moved or moves through the continuum of treatment, care and support. The referral process should include helping patients connect to services.</p>

                            <h4 class="mt-4">3.7.2 Types of Referrals</h4>
                            <div class="comparison-chart">
                                <div class="chart-row">
                                    <div class="chart-label">Passive Referral</div>
                                    <div class="chart-bars">Referral form given to patient to submit to facility themselves.</div>
                                </div>
                                <div class="chart-row">
                                    <div class="chart-label">Active Referral</div>
                                    <div class="chart-bars">Done through patient escorts to the referred health facility.</div>
                                </div>
                            </div>
                            <p class="mt-2"><strong>Referral Services Include:</strong> Prevention, advocacy, spiritual support, Psychosocial support, Nutrition support, social and legal support services, peer support, community based services, HIV clinics, specialized care facilities and hospitals for treatment of other conditions.</p>

                            <h4 class="mt-4">3.7.3 Elements of Referral Network</h4>
                            <ol class="enhanced-list">
                                <li class="list-item">A group of organizations that provide comprehensive services within a defined geographic area</li>
                                <li class="list-item">A unit or organization that coordinates and oversees the whole referral network</li>
                                <li class="list-item">Periodic meetings of network providers</li>
                                <li class="list-item">Designated referral person(s) at each organization</li>
                                <li class="list-item">A directory of services and organizations within a defined catchment area</li>
                                <li class="list-item">A standardized referral form</li>
                                <li class="list-item">A feedback loop to track referrals</li>
                                <li class="list-item">Documentation of referral</li>
                            </ol>
                        </div>
                    </section>

                    <!-- 3.8 Standard Package -->
                    <section class="content-section" id="standard-package">
                        <div class="section-header">
                            <div class="section-number">3.8</div>
                            <h2 class="section-title">
                                <span class="title-icon">üì¶</span>
                                Standard Package of Care for PLHIV
                            </h2>
                        </div>

                        <div class="content-card content-card--gradient">
                            <h3 class="card-title">8 Components of Care</h3>
                            
                            <div class="exam-checklist">
                                <div class="exam-item">
                                    <span class="exam-check">a</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Antiretroviral Therapy</h5>
                                        <p class="exam-item-text">All PLHIV qualify irrespective of CD4/Stage. Initiate ASAP (pref. within 2 weeks).</p>
                                        <p class="exam-item-text"><strong>Regimens by age:</strong><br>
                                        &lt;2wks: AZT, 3TC, NVP<br>
                                        2-4wks: AZT, 3TC, LPV/r<br>
                                        4wks-3yrs: ABC, 3TC, LPV/r<br>
                                        3-15yrs (&lt;35kg): ABC, 3TC, EFV<br>
                                        3-15yrs (&gt;35kg) / Adults (&gt;15yrs): TDF, 3TC, EFV (First line)</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">b</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Positive Health, Dignity, Prevention, GBV & Education</h5>
                                        <p class="exam-item-text">Counseling on disclosure, partner testing, condoms, FP. Screen females 15-49 for GBV. Provide health education.</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">c</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Screening & Prevention of OIs</h5>
                                        <p class="exam-item-text">Lifelong Cotrimoxazole (CPT). TB screening at every visit (ICF tool) & IPT if negative. Cryptococcal screening for adults with CD4 ‚â§ 100.</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">d</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Reproductive Health Services</h5>
                                        <p class="exam-item-text">STI screening every visit. Pregnancy status/contraception needs. Cervical cancer screening for women 18-65.</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">e</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">NCD Screening & Management</h5>
                                        <p class="exam-item-text">Lifestyle modifications for hypertension, diabetes, dyslipidaemia.</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">f</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Mental Health Screening</h5>
                                        <p class="exam-item-text">Screen for depression before ART and annually. Screen for alcohol/drug use.</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">g</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Nutrition Services</h5>
                                        <p class="exam-item-text">Nutritional assessment, counselling, and support (NACS).</p>
                                    </div>
                                </div>

                                <div class="exam-item">
                                    <span class="exam-check">h</span>
                                    <div class="exam-content">
                                        <h5 class="exam-item-title">Prevention of Other Infections</h5>
                                        <p class="exam-item-text">Vaccinations per National Programme.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- 3.9 CHA Role -->
                    <section class="content-section" id="cha-role">
                        <div class="section-header">
                            <div class="section-number">3.9</div>
                            <h2 class="section-title">
                                <span class="title-icon">üßë‚Äç‚öïÔ∏è</span>
                                Role of Community Health Assistant
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item">Refer people living with HIV for care and treatment- ensure access to health workers providing quality care; and drive investment and accountability through political leadership</li>
                                <li class="list-item">Tracing of TB and ART defaulters- Follow doctor's orders about your prescriptions.</li>
                                <li class="list-item">Sensitizing the community on HIV</li>
                                <li class="list-item">Counseling- Manage physical and emotional health problems</li>
                                <li class="list-item">Practice safe sex. This is paramount on the list.</li>
                                <li class="list-item">Enable individuals and communities affected by HIV to take charge of their own health and that of their loved ones;</li>
                                <li class="list-item">Get tested for other STDs.</li>
                                <li class="list-item">Prevent infections and illnesses.</li>
                                <li class="list-item">Don't abuse drugs or alcohol and quit smoking.</li>
                                <li class="list-item">Exercise mind and body.</li>
                            </ul>
                        </div>
                    </section>

                </main>

                <!-- Quiz Section -->
                <section class="quiz-section" id="topic-quiz" aria-labelledby="quiz-title">
                    <div class="quiz-header">
                        <div class="quiz-badge">
                            <span class="quiz-icon">üìù</span>
                            <span>Knowledge Check</span>
                        </div>
                        <h2 id="quiz-title" class="quiz-title">Test Your Understanding</h2>
                        <p class="quiz-description">Complete this quiz to assess your comprehension of Unit 3: Management of HIV and AIDS.</p>
                    </div>
                    
                    <div class="quiz-container" 
                         data-quiz-id="topic-03-quiz"
                         data-quiz-js="../quizzes/topic-03-quiz.js">
                        <div class="quiz-loading">
                            <div class="quiz-spinner"></div>
                            <p>Loading quiz...</p>
                        </div>
                        <div class="quiz-content" hidden></div>
                        <div class="quiz-results" hidden></div>
                    </div>
                </section>

                <!-- Bottom Navigation -->
                <nav class="document-nav" role="navigation">
                    <div class="nav-links">
                        <a href="topic-02-prevention.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Prev: Unit 2</span>
                        </a>

                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>

                        <a href="../quiz-hub.html" class="nav-button nav-button--quiz">
                            <span class="nav-icon">üìù</span>
                            <span class="nav-text">All Quizzes</span>
                        </a>

                        <a href="topic-04-sbcc.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next: SBCC</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close">&times;</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
    <script src="../js/quiz.js"></script>
</body>

</html>